What we do ProteinExpress focuses its business on exploring and validating seeds of novel drugs as a genome-based drug discovery company. Our business is based on recombinant DNA technology for effective protein production. Genome-based Drug Seed Development Projects   Genome-based Drug Discovery Project   - Targeting genes for drug discovery   - Identifying target proteins by proteomics   - Validating drug seeds KIAA Project   - Producing antibodies as a proteome analysis tool - Proteomics with the utilization of antibodies Other Business Activities   Development of protein-based pharmaceuticals Protein expression & production service